XML 39 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Jan. 01, 2022
Product Information [Line Items]            
Revenue $ 417,000 $ 399,000 $ 21,146,000 $ 1,878,000    
Accounts receivable $ 417,000   $ 417,000   $ 1,000,000  
Incremental borrowing rate 6.00%   6.00%      
Impairment of lab equipment     33,000 227,000  
Capitalized contract assets $ 0   0   2,100,000  
Amortization of contract assets 0 $ 0 0 $ 0    
Contract assets, impaired 0   2,100,000      
Accumulated other comprehensive income $ 7,787,000   $ 7,787,000   5,051,000  
Weighted-average common shares outstanding used in computing net loss per share available to common stockholders, basic 37,428,943 17,701,592 35,562,129 17,701,592    
Weighted-average common shares outstanding used in computing net loss per share available to common stockholders, diluted 37,428,943 17,701,592 47,178,967 17,701,592    
Recognition of lease liabilities           $ 2,300,000
Recognition of lease assets           $ 1,900,000
Minimum [Member]            
Product Information [Line Items]            
Estimated useful life 3 years   3 years      
Maximum [Member]            
Product Information [Line Items]            
Estimated useful life 5 years   5 years      
Customer One [Member]            
Product Information [Line Items]            
Accounts receivable $ 400,000   $ 400,000   $ 1,000,000.0  
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]            
Product Information [Line Items]            
Revenue 400,000          
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Three Customer [Member]            
Product Information [Line Items]            
Revenue   $ 400,000 $ 1,500,000 $ 1,900,000    
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]            
Product Information [Line Items]            
Concentration risk percentage     3.00% 27.00%    
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]            
Product Information [Line Items]            
Concentration risk percentage     12.00% 34.00%    
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer Three [Member]            
Product Information [Line Items]            
Concentration risk percentage     85.00% 39.00%    
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | Customer [Member]            
Product Information [Line Items]            
Concentration risk percentage     7.00% 100.00%    
License [Member] | Customer Concentration Risk [Member] | One Customer [Member]            
Product Information [Line Items]            
Revenue $ 0 $ 0 $ 19,600,000 $ 0